Donate

Subcutaneous DMPA: Evidence, Experience, and Resources for Introduction

Subcutaneous DMPA (DMPA-SC, brand name Sayana Press) is an innovative injectable contraceptive that can dramatically expand access and choice for women. A new initiative led by PATH and John Snow Inc., the DMPA-SC Access Collaborative is working with ministries of health and partners across sectors to strengthen scale-up and build toward a robust global market for the product.

During this October 2017 webinar, presenters provided an overview of tools, resources, and references for DMPA-SC introduction planning and implementation, as well as self-injection program design. Presenters also discussed the Access Collaborative’s forthcoming work with ministries of health and partners to facilitate introduction and scale-up.

For more information, visit the DMPA-SC Access Collaborative page or email FPoptions@path.org.

Author(s): Christenson K, Wood S, Namagembe A, Feinberg J

Corporate author(s): PATH, John Snow, Inc.

Publication date: October 2017

Available materials

  1. English

    1. Subcutaneous DMPA: Evidence, Experience, and Resources for Introduction 3.5 MB PDF

      Webinar presentation slides

  2. English

    1. Subcutaneous DMPA: Evidence, Experience, and Resources for Introduction

      Webinar recording